Biogen
BIIB
BIIB
1,006 hedge funds and large institutions have $36.1B invested in Biogen in 2023 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 320 increasing their positions, 363 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less call options, than puts
Call options by funds: $555M | Put options by funds: $599M
5% less funds holding in top 10
Funds holding in top 10: 19 → 18 (-1)
12% less repeat investments, than reductions
Existing positions increased: 320 | Existing positions reduced: 363
Holders
1,006
Holding in Top 10
18
Calls
$555M
Puts
$599M
Top Buyers
| 1 | +$1.01B | |
| 2 | +$264M | |
| 3 | +$181M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$109M |
| 5 |
JP Morgan Chase
New York
|
+$108M |
Top Sellers
| 1 | -$668M | |
| 2 | -$286M | |
| 3 | -$157M | |
| 4 |
D.E. Shaw & Co
New York
|
-$145M |
| 5 |
Millennium Management
New York
|
-$140M |